Search for Clinical Trial Results

Ascites - 120 Studies Found
Status | Study |
Terminated |
Study Name: Trial of Sunitinib for Refractory Malignant Ascites Condition: Ascites Date: 2008-11-21 Interventions: Drug: Sunitinib Patients will be given Sunitinib 50 mg orally daily for four weeks, followed by a two we |
Completed |
Study Name: Safety and Performance of the Automated Fluid Shunt in Patients With Ascites and Diuretic Resistance Condition: Ascites Date: 2009-12-10 Interventions: Device: NovaShunt's Automated Fluid Shunt implantation The Automated Fluid Shunt (AFS) Device consists o |
Terminated |
Study Name: Sodium Restriction in the Management of Cirrhotic Ascites Condition: Ascites Date: 2007-10-22 Interventions:
|
Completed |
Study Name: To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites Condition: Ascites Date: 2015-12-05 Interventions:
|
Terminated |
Study Name: An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Pleurx Catheters in Patients With Malignant Ascites Condition: Malignant Ascites Date: 2010-02-25 Interventions:
|
Recruiting |
Study Name: Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology Condition: Refractory Malignant Ascites Date: 2015-06-16 Interventions:
|
Withdrawn |
Study Name: A Study of Bevacizumab to Prevent Malignant Ascites Condition: Malignant Ascites Date: 2009-05-21 Interventions: Drug: Bevacizumab Bevacizumab is given as an IV infusion of 15 mg/kg every three weeks for 12 weeks. |
Active, not recruiting |
Study Name: Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites Condition: Ascites Date: 2010-08-24 Interventions: Behavioral: McGill Quality of Life Questionnaire and the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire |
Completed |
Study Name: Symptomatic Ascites Drainage With a Patient-controlled Vascular Catheter. Condition: Malignant Ascites Date: 2016-03-20 Interventions:
|
Completed |
Study Name: Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites Condition: Malignant Ascites Date: 2006-05-15 Interventions: Drug: catumaxomab Catumaxomab is administered intraperitoneally via an indwelling catheter (or port) as |